Skip to main content

FDA authorization of AstraZeneca vaccine may hinge on U.S. trial

The U.S. Food and Drug Administration is unlikely to authorize AstraZeneca’s Covid-19 vaccine candidate prior to the completion of a large U.S. trial in the coming months, a top government adviser said on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.